N. Bodor et P. Buchwald, Recent advances in the brain targeting of neuropharmaceuticals by chemicaldelivery systems, ADV DRUG DE, 36(2-3), 1999, pp. 229-254
Brain-targeted chemical delivery systems represent a general and systematic
method that can provide localized and sustained release for a variety of t
herapeutic agents including neuropeptides. By using a sequential metabolism
approach, they exploit the specific trafficking properties of the blood-br
ain barrier and provide site-specific or site-enhanced delivery. After a br
ief description of the design principles, the present article reviews a num
ber of specific delivery examples (zidovudine, ganciclovir, lomustine benzy
lpenicillin, estradiol, enkephalin, TRH, kyotorphin), together with represe
ntative synthetic routes, physicochemical properties, metabolic pathways, a
nd pharmacological data. A reevaluated correlation for more than 60 drugs b
etween previously published in vivo cerebrovascular permeability data and o
ctanol/water partition coefficients is also included since it may be useful
in characterizing the properties of the blood-brain barrier, including act
ive transport by P-glycoprotein. (C) 1999 Elsevier Science BN. All rights r
eserved.